OPTISOL
OPTISOL has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €555k and a net result of €148k. Equity is growing by ~8.9% per year across the filed fiscal years. Its solvency ranks better than 46% of 17540 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
| Equity | €555k |
| Net result | €148k |
| Better than sector | 46% |
| Active | 17 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 30.0% | 34.6% | |
| Net result | €148k | €5k | |
| Equity | €555k | €44k | |
| Gross operating margin | €424k | €34k | |
| Staff costs | €76k | €40k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €346k | €176k | €160k | €114k | €165k |
| Net profit | €148k | €17k | €46k | €60k | €73k |
| Cash flow | €272k | €138k | €134k | €88k | €98k |
| Staff costs | €76k | €54k | €37k | - | - |
| Income taxes | €58k | €15k | €5k | €6k | €60k |
| Dividends | - | €0 | €37k | €26k | €17k |
| Total assets | €1.85M | €1.77M | €1.82M | €1.33M | €638k |
| Equity | €555k | €407k | €390k | €382k | €347k |
| Debt | €1.29M | €1.37M | €1.43M | €951k | €291k |
| of which ≤ 1y | €242k | €224k | €263k | €193k | €75k |
| of which > 1y | €1.05M | €1.14M | €1.16M | €759k | €216k |
| Working capital | €245k | €128k | €24k | €184k | €249k |
| Employees (FTE) | - | 1.3 | 1.0 | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 2.01 | 1.57 | 1.09 | 1.95 | 4.33 |
| Quick ratio | 1.24 | 0.78 | 0.50 | 1.36 | 2.95 |
| Working capital ratio | 13.3% | 7.2% | 1.3% | 13.8% | 39.1% |
| Solvency | 30.0% | 23.0% | 21.5% | 28.6% | 54.4% |
| Debt / equity | 2.33 | 3.35 | 3.65 | 2.49 | 0.84 |
| Long-term debt ratio | 1.89 | 2.80 | 2.98 | 1.99 | 0.62 |
| Interest coverage | 13.24 | 6.17 | 6.95 | 5.38 | 20.70 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 8.0% | 1.0% | 2.5% | 4.5% | 11.4% |
| ROE | 26.6% | 4.2% | 11.8% | 15.7% | 21.0% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Full annual accounts (26 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €1.85M | €1.77M | €1.82M | €1.33M | €638k |
| Fixed assets | 21/28 | €1.36M | €1.42M | €1.53M | €956k | €314k |
| Intangible fixed assets | 21 | - | €0 | €2k | €4k | €6k |
| Tangible fixed assets | 22/27 | €1.36M | €1.42M | €1.52M | €950k | €305k |
| Financial fixed assets | 28 | - | €0 | €3k | €3k | €3k |
| Current assets | 29/58 | €487k | €352k | €287k | €377k | €324k |
| Stocks & contracts in progress | 3 | €188k | €177k | €156k | €115k | €104k |
| Amounts receivable within one year | 40/41 | €93k | €80k | €25k | €22k | - |
| Cash & bank | 54/58 | €197k | €89k | €103k | €221k | €182k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.85M | €1.77M | €1.82M | €1.33M | €638k |
| Equity | 10/15 | €555k | €407k | €390k | €382k | €347k |
| Contributions / capital | 10/11 | €6k | €6k | €6k | €6k | €6k |
| Reserves | 13 | €518k | €370k | €353k | €344k | €310k |
| Accumulated profits (losses) | 14 | €31k | €31k | €31k | €31k | €31k |
| Amounts payable | 17/49 | €1.29M | €1.37M | €1.43M | €951k | €291k |
| Amounts payable after one year | 17 | €1.05M | €1.14M | €1.16M | €759k | €216k |
| Amounts payable within one year | 42/48 | €242k | €224k | €263k | €193k | €75k |
| Trade debts payable within one year | 44 | €73k | €69k | €119k | €86k | €14k |
| Income statement | ||||||
| Gross operating margin | 9900 | €424k | €232k | €199k | €125k | €166k |
| Operating result | 9901 | €222k | €55k | €72k | €86k | €140k |
| Financial income | 75 | €10k | €5k | €2k | €1k | €1k |
| Financial charges | 65 | €26k | €29k | €23k | €21k | €8k |
| Result before taxes | 9903 | €206k | €32k | €51k | €66k | €133k |
| Income taxes | 67/77 | €58k | €15k | €5k | €6k | €60k |
| Net result for the period | 9904 | €148k | €17k | €46k | €60k | €73k |
| Result to be appropriated | 9905 | €148k | €17k | €46k | €60k | €159k |
| NACE primary | Retail sale of prescription glasses, lenses and sunglasses(47742) |
| Legal form | Private limited company(610) |
| Incorporation | 17-03-2009 |
| Status | Active |
| Postal code | 1320 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25038C0096/00D002indicative | Wallonia | 270 m² | 1 · 81 m² | - |
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameFR | OPTISOL |